INDV vs TVTX: stock comparison and AI forecast
Indivior Pharmaceuticals, Inc. (INDV) and Travere Therapeutics, Inc. (TVTX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
INDV Indivior Pharmaceuticals, Inc.
- Price
- $35.37 -3.8% · 6M
- Market Cap
- $4.17B
- P/E Ratio
- 8.6x
- Size
- mid-cap
- AI Forecast
- NO CURRENT FORECAST
TVTX Travere Therapeutics, Inc.
- Price
- $49.26 +9.7% · 6M
- Market Cap
- $4.41B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- INDV and TVTX have similar market capitalizations ($4.17B and $4.41B).
- Over the last six months TVTX returned +9.7% and INDV -3.8%.
- INDV turns 32.1% of its revenue into net income, against -18.7% for TVTX.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | INDV | TVTX |
|---|---|---|
| Market Cap | $4.17B | $4.41B |
| P/E Ratio | 8.63x | – |
| P/B Ratio | – | 195.23x |
| EPS | $4.10 | $-1.12 |
| Book Value/Share | – | $0.25 |
| Revenue/Share | $11.63 | $7.27 |
| FCF/Share | $0.26 | – |
Profitability & Margins
| Metric | INDV | TVTX |
|---|---|---|
| ROE | – | -538.0% |
| ROA | – | -14.3% |
| ROIC | – | -20.9% |
| Gross Margin | 84.8% | 98.5% |
| Operating Margin | 41.0% | -20.5% |
| Net Margin | 32.1% | -18.7% |
| EBT Margin | 39.6% | -24.5% |
| Tax Rate | 16.5% | 3.3% |
Financial Health
| Metric | INDV | TVTX |
|---|---|---|
| Current Ratio | 0.61x | 3.00x |
| Quick Ratio | 0.50x | 2.80x |
| D/E Ratio | – | 36.56x |
| Financial Leverage | – | 37.56x |
| Interest Coverage | 6.8x | -3.7x |
| Working Capital | -$501M | $423M |
Cash Flow
| Metric | INDV | TVTX |
|---|---|---|
| Operating Cash Flow | $96M | $177M |
| Free Cash Flow | $31M | – |
| Capital Spending | -$65M | – |
| OCF Growth YoY | -52.7% | – |
| FCF Growth YoY | -79.8% | – |
| FCF/Sales | 2.3% | – |
| CapEx/Sales | 4.7% | – |
Operational Efficiency
| Metric | INDV | TVTX |
|---|---|---|
| Asset Turnover | – | 0.77x |
| Receivables Turnover | 5.0x | 6.0x |
| Inventory Turnover | 1.4x | 0.2x |
| Fixed Assets Turnover | 7.8x | 239.0x |
| Days Sales Outstanding | 73 days | 60 days |
| Days Inventory | 261 days | 1675 days |
| Payables Period | 49 days | 584 days |
| Cash Conversion Cycle | 285 days | 1151 days |
Income Statement
| Metric | INDV | TVTX |
|---|---|---|
| Total Revenue | $1.37B | $651M |
| Operating Income | $558M | -$134M |
| Net Income | $436M | -$122M |
| R&D Expense | $54M | $246M |
| SG&A Expense | $553M | $376M |
| Cost of Goods Sold | $208M | $10M |
Dividend & Shareholder Information
| Metric | INDV | TVTX |
|---|---|---|
| Shares Outstanding | 118M | 90M |
| Net Income Growth | 305.6% | – |
| EPS Growth | 1123.9% | – |
INDV vs TVTX: stock comparison and AI forecast
Which is bigger, INDV or TVTX?
INDV and TVTX have similar market capitalizations ($4.17B and $4.41B).
Which stock performed better over the last six months, INDV or TVTX?
Over the last six months TVTX returned +9.7% and INDV -3.8%.
Which one does Intratio's AI model rank higher, INDV or TVTX?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.